Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jorge D. Mendez-Rios

SPI-1 Is a Missing Host-Range Factor Required for Replication of the Attenuated Modified Vaccinia Ankara (MVA) Vaccine Vector in Human Cells

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2019English

Related publications

Highly Attenuated Modified Vaccinia Virus Ankara (MVA) as an Effective Recombinant Vector: A Murine Tumor Model

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
1997English

Attenuation and Immunogenicity of Host-Range Extended Modified Vaccinia Virus Ankara Recombinants

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2013English

088 Skin Delivery of Modified Vaccinia Ankara (MVA) Virus Generates Superior Protective Pulmonary Immunity

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Chemokine (C-C Motif) Receptor 1 Is Required for Efficient Recruitment of Neutrophils During Respiratory Infection With Modified Vaccinia Virus Ankara

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2014English

The Orthopoxvirus 68-Kilodalton Ankyrin-Like Protein Is Essential for DNA Replication and Complete Gene Expression of Modified Vaccinia Virus Ankara in Nonpermissive Human and Murine Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent Under Conditions of Preexisting Immunity to the Vector

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies

PLoS ONE
Multidisciplinary
2009English

A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination

PLoS ONE
Multidisciplinary
2009English

092 Approaches to Generating Protective T Cell Vaccines to Conserved Influenza Epitopes Using Modified Vaccinia Ankara (MVA) Vector Vaccines Delivered Through Skin

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy